University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome

Completed

Conditions: Ulcerative Colitis
Healthy
Crohn Disease
Celiac Disease
Irritable Bowel Syndrome

First Posted Date: 2017-02-13

Last Posted Date: 2023-09-22

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 175

Registration Number: NCT03051204

Locations: 🇺🇸
UCLA Center for Inflammatory Bowel Diseases, Los Angeles, California, United States

Grade Book Game Evaluation Among 6th Grade Students

Completed

Conditions: Adolescent Behaviors

Interventions: Other: Gradebook Game

First Posted Date: 2017-02-01

Last Posted Date: 2017-10-30

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 100

Registration Number: NCT03039894

Locations: 🇺🇸
UCLA, Los Angeles, California, United States

Attention Training for Underserved Youth With Anxiety

Not Applicable

Completed

Conditions: Anxiety

Interventions: Behavioral: Attention Modification Program
Behavioral: Attention Control Condition

First Posted Date: 2017-01-23

Last Posted Date: 2022-07-26

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 69

Registration Number: NCT03028792

Locations: 🇺🇸
Clinicas de Salud del Pueblo healthcare system, El Centro, California, United States

The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy

Phase 4

Completed

Conditions: Wet Macular Degeneration

Interventions: Drug: Aflibercept Ophthalmic
Device: optovue angiovue

First Posted Date: 2017-01-16

Last Posted Date: 2022-01-06

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 26

Registration Number: NCT03022292

Locations: 🇺🇸
Stein Eye Institute of UCLA, Los Angeles, California, United States

STI Screening as a Combined HIV Prevention Platform for MSM in Peru

Not Applicable

Completed

Conditions: Chlamydia of Rectum
HIV Infections
Gonorrhoea of Rectum

Interventions: Behavioral: Traditional Counseling
Behavioral: PCC

First Posted Date: 2017-01-04

Last Posted Date: 2018-08-07

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 150

Registration Number: NCT03010020

Locations: 🇵🇪
Asociacion Civil Via Libre, Lima, Peru

Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID

Phase 1

Completed

Conditions: Severe Combined Immunodeficiency Due to ADA Deficiency

Interventions: Genetic: Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101)
Drug: busulfan
Drug: PEG-ADA ERT

First Posted Date: 2016-12-21

Last Posted Date: 2022-08-03

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 10

Registration Number: NCT02999984

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Testosterone for Fatigue in Men With MS

Phase 2

Withdrawn

Conditions: Multiple Sclerosis

Interventions: Drug: AndroGel 1 % Topical Gel
Drug: Placebos

First Posted Date: 2016-12-21

Last Posted Date: 2019-11-06

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT03000127

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸
Washington University, Saint Louis, Missouri, United States

Cord Milking Impacts Neurodevelopmental Outcomes in Very Low Birth Weight Infants

Not Applicable

Terminated

Conditions: Very Low Birth Weight Infant

Interventions: Other: cord milking

First Posted Date: 2016-12-09

Last Posted Date: 2018-10-15

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 5

Registration Number: NCT02987764

Locations: 🇺🇸
Mattel Children's Hospital UCLA, Los Angeles, California, United States

Laboratory-based Hypnosis Intervention on Pain Responsivity in Adolescents With Sickle Cell Disease

Not Applicable

Completed

Conditions: Sickle Cell Disease

Interventions: Behavioral: Attention Control
Behavioral: Hypnosis

First Posted Date: 2016-12-09

Last Posted Date: 2020-11-04

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 25

Registration Number: NCT02987725

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Identification and Removal of the Non Palpable Etonogestrel Contraceptive Implant

Not Applicable

Completed

Conditions: Women With an ENG Contraceptive Implant

Interventions: Procedure: continuation of ING implant
Procedure: removal of ENG implant

First Posted Date: 2016-12-08

Last Posted Date: 2021-04-30

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 40

Registration Number: NCT02986204

Locations: 🇺🇸
UCLA Dept. OB/GYN, Women's Health CRU, 10833 Le Conte Ave, CHS 22-265, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy